These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11572156)

  • 1. Clinical use of granulocyte colony-stimulating factor in infectious diseases.
    Gaviria JM; Garrido SM; Root RK
    Curr Clin Top Infect Dis; 2001; 21():302-22. PubMed ID: 11572156
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factors in the prevention and management of infectious diseases.
    Page AV; Liles WC
    Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in cancer patients treated with hematopoietic growth factors--a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH.
    Barbui T; Finazzi G; Grassi A; Marchioli R
    Thromb Haemost; 1996 Feb; 75(2):368-71. PubMed ID: 8815592
    [No Abstract]   [Full Text] [Related]  

  • 8. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases.
    Dale DC; Liles WC; Summer WR; Nelson S
    J Infect Dis; 1995 Oct; 172(4):1061-75. PubMed ID: 7561181
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for the use of granulocyte growth factors].
    Elonen E
    Duodecim; 1997; 113(22):2319-25. PubMed ID: 10892137
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
    Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Granulocyte colony-stimulating factors as a support therapy in malignant diseases].
    Riikonen P; Elonen E; Teerenhovi L
    Duodecim; 2002; 118(21):2249-54. PubMed ID: 12486962
    [No Abstract]   [Full Text] [Related]  

  • 13. Acting on imperfect evidence: How much regret are we ready to accept?
    Djulbegovic B; Frohlich A; Bennett CL
    J Clin Oncol; 2005 Oct; 23(28):6822-5. PubMed ID: 16145058
    [No Abstract]   [Full Text] [Related]  

  • 14. Off-label use of granulocyte colony-stimulating factor in noncongenital neutropenia: retrospective data from the Italian Neutropenia Registry.
    Fioredda F; Calvillo M; Renga D; Bonanomi S; Ciliberti A; Martire B; Ghilardi R; Dufour C
    Pediatr Hematol Oncol; 2008 Jun; 25(4):371-4. PubMed ID: 18484485
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factors as therapeutic agents.
    Donahue RE; Clark SC
    Immunol Ser; 1992; 57():637-49. PubMed ID: 1380310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Granulocyte colony-stimulating factor and HIV infection].
    Miguélez M; Laynez P; Linares M
    Med Clin (Barc); 1995 Feb; 104(4):157. PubMed ID: 7534854
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia.
    Kikkawa M; Matsubara S; Takatoku M; Kuwata T; Ohkuchi A; Izumi A; Watanabe T; Suzuki M
    J Obstet Gynaecol Res; 2008 Apr; 34(2):286-90. PubMed ID: 18412800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.